Home › Funds › WEDGEWOOD PARTNERS INC › EW

WEDGEWOOD PARTNERS INC position in EW

EDWARDS LIFESCIENCES CORP · Health Care

WEDGEWOOD PARTNERS INC reported holding 151,007 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$13.0M, representing 2.83% of its reported portfolio and ranking #15 among its reported holdings. WEDGEWOOD PARTNERS INC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)151.01K sh
Reported value held$13.03M
Portfolio Weight2.83%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How WEDGEWOOD PARTNERS INC's EW position evolved

WEDGEWOOD PARTNERS INC first disclosed a stake in EW in Q3 2023 at 193,797 shares (US$13.4M). The position peaked in Q4 2024 at 339,436 shares, worth US$25.1M. Across 13 filings, WEDGEWOOD PARTNERS INC increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 151,007 shares valued at US$13.0M — a reduction of -14,201 shares quarter over quarter.. Notable position changes include a 29% increase in Q4 2023 (shares rose 25% over the following quarter), a 44% increase in Q2 2024 (shares fell 29% over the following quarter), a 43% trim in Q1 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 193.80K $13.43M New
Q4 2023 250.65K $21.62M Add
Q1 2024 245.45K $22.13M Reduce
Q2 2024 354.43K $23.23M Add
Q3 2024 359.26K $23.90M Add
Q4 2024 339.44K $25.13M Reduce
Q1 2025 191.82K $14.72M Reduce
Q2 2025 178.03K $14.26M Reduce
Q3 2025 184.70K $14.36M Add
Q4 2025 180.88K $15.42M Reduce
Q1 2026 170.97K $13.69M Reduce
Q2 2026 165.21K $14.94M Reduce
Q3 2026 151.01K $13.03M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 28 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), Ninety One UK Ltd (US$1.03B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$923.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has WEDGEWOOD PARTNERS INC held EW?

WEDGEWOOD PARTNERS INC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WEDGEWOOD PARTNERS INC's current position in EW?

As of Q3 2026, WEDGEWOOD PARTNERS INC holds 151.01K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $13.03M, representing 2.83% of its reported portfolio and ranking #15.

Has WEDGEWOOD PARTNERS INC been buying or selling EW?

In the latest 13F filing (Q3 2026), WEDGEWOOD PARTNERS INC reduced its position in EW. The position peaked in Q4 2024 at 339.44K shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, Ninety One UK Ltd, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.